Clinical Trial Update: BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial of BI 443651 in healthy volunteers followed by crossover in cystic fibrosis subjects completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• BI 443651

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2019-11-27